SCHEMBL1226041

SCHEMBL1226041

O=C(O)CCC(F)(F)CC1CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 2/20 0.35
KDM4C Q9H3R0 2/20 0.35
PHF8 Q9UPP1 2/20 0.35
KDM2A Q9Y2K7 2/20 0.35
KDM7A Q6ZMT4 1/20 0.35
MAPT P10636 1/20 0.34
ALDH1A1 P00352 2/20 0.33
LMNA P02545 2/20 0.32
ALKBH5 Q6P6C2 1/20 0.32
SUCNR1 Q9BXA5 1/20 0.32
EGLN1 Q9GZT9 1/20 0.32
ITGB3 P05106 2/20 0.32
ITGA2B P08514 2/20 0.32
THRB P10828 2/20 0.32
THRA P10827 1/20 0.32
SLC6A1 P30531 2/20 0.31
GABRA5 P31644 2/20 0.31
GABRB2 P47870 2/20 0.31
SLC6A12 P48065 2/20 0.31
SLC6A11 P48066 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5936852 0.83 KDM5A (0.39) KDM5AKDM4CPHF8KDM2AKDM7A
SCHEMBL12987414 0.77 LMNA (0.47) PHF8KDM2AALDH1A1LMNAALKBH5
SCHEMBL5936837 0.76 KDM5A (0.38) KDM5AKDM4CPHF8KDM2AKDM7A
SCHEMBL5936833 0.76 HPGD (0.42) KDM5AKDM4CPHF8KDM2AKDM7A
SCHEMBL5936777 0.75 HPGD (0.44) KDM5AKDM4CPHF8KDM2AALDH1A1
SCHEMBL15621601 0.70 LMNA (0.40) ALDH1A1LMNAALKBH5SUCNR1EGLN1
SCHEMBL11264031 0.70 LMNA (0.40) ALDH1A1LMNAALKBH5SUCNR1EGLN1
SCHEMBL672141 0.69 KDM5A (0.47) KDM5AKDM4CPHF8KDM2AKDM7A
SCHEMBL8920891 0.69 KDM5A (0.47) KDM5AKDM4CPHF8KDM2AKDM7A
SCHEMBL301024 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8324417-B2 Process for the preparation of (S)-2-amino-5-cyclopropyl-4,4-difluoropentanoic acid and alkyl esters and acid salts thereof VIROBAY, INC. (US) 2012-12-04 US disclosed
US-20110046406-A1 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF VIROBAY, INC. (US) 2011-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046406-A1 PROCESS FOR THE PREPARATION OF (S)-2-AMINO-5-CYCLOPROPYL-4,4-DIFLUOROPENTANOIC ACID AND ALKYL ESTERS AND ACID SALTS THEREOF DNPEP, CTRL, CTSS KDM5A 1349/4885KDM4C 1678/4885PHF8 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.